A Novel Genetically Modified Adenovirus Vector Shows Enhanced Infectivity towards Ex Vivo Pancreatic Cancer

被引：0
|
作者：
van Geer, Michael [1 ]
Bosma, Piter [1 ]
Kuhlmann, Koert [2 ]
Bakker, Conny [1 ]
Gouma, Dirk [2 ]
Elferink, Ronald Oude [1 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, AMC Liver Ctr, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands
来源：
MOLECULAR THERAPY | 2006年 / 13卷
关键词：
D O I：
10.1016/j.ymthe.2006.08.864
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
778
引用
收藏
页码：S301 / S301
页数：1
相关论文
共 48 条
  • [41] In Vitro and In Vivo Comparison of Gemcitabine and the Gemcitabine Analog 1-(2'-deoxy-2'-fluoroarabinofuranosyl) Cytosine (FAC) in Human Orthotopic and Genetically Modified Mouse Pancreatic Cancer Models
    Russell, James
    Pillarsetty, Nagavarakishore
    Kramer, Robin M.
    Romesser, Paul B.
    Desai, Pooja
    Haimovitz-Friedman, Adriana
    Lowery, Maeve A.
    Humm, John L.
    MOLECULAR IMAGING AND BIOLOGY, 2017, 19 (06) : 885 - 892
  • [42] Identifying the Safety Profile of Ad5.SSTR/TK.RGD, a Novel Infectivity-Enhanced Bicistronic Adenovirus, in Anticipation of a Phase I Clinical Trial in Patients with Recurrent Ovarian Cancer
    Matthews, Kellie
    Noker, Patricia E.
    Tian, Baohong
    Grimes, Sheila D.
    Fulton, Ronna
    Schweikart, Karen
    Harris, Raymond
    Aurigemma, Rose
    Wang, Minghui
    Barnes, Mack N.
    Siegal, Gene P.
    Hemminki, Akseli
    Zinn, Kurt
    Curiel, David T.
    Alvarez, Ronald D.
    CLINICAL CANCER RESEARCH, 2009, 15 (12) : 4131 - 4137
  • [43] A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer
    Kim, Kenneth H.
    Dmitriev, Igor P.
    Saddekni, Souheil
    Kashentseva, Elena A.
    Harris, Raymond D.
    Aurigemma, Rosemarie
    Bae, Sejong
    Singh, Karan P.
    Siegal, Gene P.
    Curiel, David T.
    Alvarez, Ronald D.
    GYNECOLOGIC ONCOLOGY, 2013, 130 (03) : 518 - 524
  • [44] Enhanced Pancreatic Cancer Gene Therapy by Combination of Adenoviral Vector Expressing c-erb-B2 (Her-2/neu)-Targeted Immunotoxin with a Replication-Competent Adenovirus or Etoposide
    Liu, Xinjian
    Li, Jinjun
    Tian, Yuhua
    Xu, Ping
    Chen, Xiafang
    Xie, Kuangchen
    Qiu, Zhengjun
    Wang, Yufei
    Zhang, Dabing
    Wolf, Frank
    Li, Chuanyuan
    Huang, Qian
    HUMAN GENE THERAPY, 2010, 21 (02) : 157 - 170
  • [45] Adenovirus vector-mediated Gli1 siRNA induces growth inhibition and apoptosis in human pancreatic cancer with Smo-dependent or Smo-independent Hh pathway activation in vitro and in vivo
    Guo, Jiefang
    Gao, Jun
    Li, Zhaoshen
    Gong, Yanfang
    Man, Xiaohua
    Jin, Jing
    Wu, Hongyu
    CANCER LETTERS, 2013, 339 (02) : 185 - 194
  • [46] Enhanced Ocular Anti-Aspergillus Activity of Tolnaftate Employing Novel Cosolvent-Modified Spanlastics: Formulation, Statistical Optimization, Kill Kinetics, Ex Vivo Trans-Corneal Permeation, In Vivo Histopathological and Susceptibility Study
    Aziz, Diana
    Mohamed, Sally A.
    Tayel, Saadia
    Makhlouf, Amal
    PHARMACEUTICS, 2022, 14 (08)
  • [47] Direct evidence for a pro-tumor role of APOBEC3A in cancer initiation and progression in vivo: enhanced mutagenesis and immune suppression in a novel humanized autochthonous model of pancreatic cancer
    Woermann, Sonja
    Cowan, Robert
    Ross, Susan M.
    Rhim, Andrew D.
    CANCER RESEARCH, 2017, 77
  • [48] Identifying the safety profile of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in anticipation of a phase I clinical trial in patients with recurrent ovarian cancer and other selected gynecologic cancers
    Matthews, K. S.
    Noker, P.
    Tian, B.
    Grimes, S.
    Fulton, R.
    Schweikart, K.
    Harris, R.
    Aurigemma, R.
    Wang, M.
    Curiel, D. T.
    Alvarez, R. D.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S111 - S112
12345